Med-Surg: Chapter 42: Adrenal Cortex Hyperfunction Flashcards

1
Q

What is Adrenal Cortex Hyperfunction a result of?

A

may be secondary to excessive secretion of glucocorticoids (hypercortisolism) or excessive secretion of aldosterone (hyperaldosteronism)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hypercortisolism

A

categorized as primary (adrenal cortex disorder), secondary (anterior pituitary gland disorder), or tertiary (hypothalamic etiology)
-Cushing’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cushing’s

A

used to describe hyperfunction of the adrenal cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cushing’s Disease

A

condition caused by excessive hormone production from an anterior pituitary tumor producing excessive ACTH or excessive hormone secretion from a primary tumor of the adrenal cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cushing’s Syndrome

A

broad term
-used to describe an excess of hormone production (CRH, ACTH, glucocorticoids), or administration of exogenous corticosteroid medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hyperaldosteronism (Conn’s Syndrome)

A

because the primary action of aldosterone is sodium and water reabsorption and potassium excretion, hypertension and hypokalemia develop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathophysiology

A
  • excessive circulating glucocorticoid (cortisol) is the pathological process associated with primary hypercortisolism
  • excessive secretion of ACTH from the anterior pituitary gland leads to hypercortisolism through its effects on the adrenal cortex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical Manifestations

A

related to hypersecretion of these hormones
-hyperglycemia
-fluid retention
-hypokalemia
-abnormal fat distribution
-decreased muscle mass
>the maldistribution of fats and changes in muscle are related to the effects that glucocorticoids have on fat and protein metabolism

> in females,

  • virilization (male sexual characteristics developing)
  • breast atrophy
  • vocal changes (deepening)
  • amenorrhea

> overproduction of cortisol also affects the immune system by decreasing inflammatory and immune responses
-lymphocytes are destroyed secondary to high levels of circulating cortisol; risk for infection

> hyperaldosteronism, usually secondary to a hypersecreting tumor of the adrenal cortex, or hyperplasia, results in increased aldosterone production

  • secondary to the action of aldosterone, sodium and water reabsorption are increased; elevated blood pressure is associated with the sodium and water retention
  • cardiac irregularities (atrial or ventricular tachyarrhythmias or U waves) secondary to hypokalemia (b/c there is an excess of potassium secretion with hyperaldosteronism)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diagnosis of Hypercortisolism

A
  • assessment of cortisol levels, results of suppression tests, and serum electrolytes
  • b/c aldosterone secretion results in both sodium and water reabsorption, there may not be an increase in serum sodium (secondary to water reabsorption)
  • patient presents with hyperglycemia (secondary to glucocorticoid activity)
  • presents with hypokalemia
  • measurement of urinary free cortisol (measures in a 24-hour period)
  • overnight dexamethasone suppression test
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Overnight Dexamethasone Suppression Test

A

evaluate hypercortisolism, specifically whether the administration of exogenous glucocorticoid (dexamethasone) inhibits the secretion of ACTH, that, in turn, decreases stimulation of cortisol release

> dexamethasone, 1 mg, is administered 11 pm followed by the collection of serum cortisol level at 8 am; results are based on whether suppression of cortisol secretion’s occur secondary to the administration of exogenous glucocorticoid

> Results:
-if the morning level is less than 2 to 3 mg/dL, normal functioning of the hypothalamic-pituitary adrenal axis is determined

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Medical Management of Hypercortisolism

A

focuses on preventing complications associated with fluid overload, changes in immune status, changes in skin integrity, and changes in body structure
-medications that interfere with ACTH and glucocorticoid production are used

> Aminoglutethimide; interferes with cortisol production in the adrenal cortex
Cyproheptadine; impacts ACTH production
-with both meds, monitor for signs of adrenal suppression (hypoglycemia and hyponatremia)

> Pasireotide (Signifor), subcutaneous somatostatin analog, used to inhibit release of corticotropin in patients with Cushing’s disease secondary to pituitary adenoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Aminoglutethimide

A

interferes with cortisol production in the adrenal cortex

-monitor for adrenal suppression (hypoglycemia, hyponatremia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cyproheptadine

A

impacts ACTH production

-monitor for adrenal suppression (hypoglycemia, hyponatremia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Surgical Management of Hypercortisolism

A

based on etiology

  • if a pituitary tumor = transsphenoidal hypophysectomy
  • with hypersecreting tumors of the adrenal cortex = adrenalectomy (removal of adrenal gland)
  • stereotactic radiosurgery of the pituitary gland = can be used in management of tumors of the pituitary gland
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diagnosis of Hyperaldosteronism

A

evaluation of serum electrolytes and imaging studies

  • elevated serum aldosterone levels
  • hypokalemia
  • hypernatremia
  • b/c hyperaldosteronism is usually secondary to hypersecreting tumors or hyperplasia, CT, or MRI may demonstrate enlargement or changes of the adrenal cortex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Medical Management Of Hyperaldosteronism

A

focus on controlling hypertension, managing hypokalemia, and determining the etiology of hyperaldosteronism

  • Hypertension treated with Spironolactone (Aldactone), a potassium sparing diuretic; potassium and sodium levels are monitored while on this medication
  • potassium supplementation may also be required b/c of loss of potassium caused by elevated aldosterone
17
Q

Medications for Hypertension in Hyperaldosteronism

A

Spironolactone (Aldactone)
-potassium-sparing diuretic

> monitor sodium and potassium levels on this medication

18
Q

Surgical Management of Hyperaldosteronism

A

adrenalectomy to remove hypersecreting tumors of the adrenal cortex

19
Q

Complications of Hypercortisolism

A

at risk for complications associated with excessive cortisol levels

  • Osteoporosis: relative to the effects of cortisol on bone density and can increase the risk of pathological fractures
  • In patients with hypercortisolism secondary to exogenous corticosteroid therapy, acute adrenal crisis may result with abrupt withdrawal of medication
  • elevated serum glucose may complicate management of diabetes mellitus
  • gastrointestinal bleeding may develop as a result of decreased mucus production in the GI tract, decreased blood flow, and release of hydrochloric acid secondary to the effects of cortisol
20
Q

Safety Alert: Patients on Exogenous Corticosteroids

A

patients receiving exogenous cortico-steroids (for their inflammatory actions) are often prescribed medications that serve as gastrointestinal prophylaxis
-b/c of the effects of corticosteroids on the GI tract, the patient must be assessed for complaints of gastrointestinal distress and GI bleeding

21
Q

Complications of Hyperaldosteronism

A

complications related to hypertension and severe hypokalemia

  • untreated hypertension leads to damage to other organs including the heart, vasculature, kidneys, and eyes
  • uncontrolled BP increases the risk for acute myocardial infarction and acute stroke (cerebrovascular accident)
  • cardiac dysrhythmias are associated with severe hypokalemia
22
Q

Nursing Management: Assessment and Analysis

A

the clinical manifestations in the patient with adrenal cortex hyperfunction are related to elevated circulating levels of cortisol or aldosterone

> Hypercortisolism: (excessive cortisol)

  • hypertension
  • hyperglycemia
  • dependent edema
  • thin, friable skin
  • fat maldistribution (truncal obesity, “moon face”, and “buffalo hump”)
  • loss of bone density
  • decreased inflammatory process
  • increased risk of infection

> Hyperaldosteronism:

  • hypertension
  • hypernatremia
  • hypokalemia
  • headache
23
Q

Nursing Diagnoses For Hypercortisolism

A
  • Fluid volume excess associated with increased sodium and water reabsorption secondary to excess glucocorticoid secretion
  • Body image disturbance associated with development of truncal obesity and fat deposition secondary to excess glucocorticoid secretion
  • Risk for infection associated with immunosuppression
  • Deficient knowledge associated with diagnosis of hypercortisolism
24
Q

Nursing Diagnosis For Hyperaldosteronism

A
  • Fluid volume excess associated with increased sodium and water reabsorption secondary to excess aldosterone secretion
  • Risk for decreased cardiac output associated with cardiac dysrhythmias secondary to hypokalemia
  • Deficient knowledge associated with management of hyperaldosteronism
25
Q

Nursing Interventions: Assessment

A

> Vital Signs:

  • suppressed immune function secondary to hypercortisolism increases the risk of infection
  • small increases in body temperature may be significant, and signs of infection may be masked b/c of immune suppression
  • blood pressure and heart rate may increase secondary to fluid retention

> Intake and Output

  • monitoring is important to evaluate trends once treatment has been started
  • urine output should increase and signs of fluid overload should decrease if treatment is effective

> Serum Glucose, Potassium

  • glucose levels rise secondary to increased secretion of glucocorticoid
  • Potassium levels also fall secondary to increased excretion via the kidneys secondary to glucocorticoid and mineralocorticoid activity

> Daily Weight

  • weight gain occurs secondary to fluid retention secondary to sodium and water reabsorption
  • peripheral edema may develop

> Skin
-thinning skin and increased friability develop secondary to excess cortisol

> Fat Distribution
-actions of glucocorticoid affect fat metabolism, leading to maldistribution of fat including truncal obesity, moon face, and buffalo hump

> Muscle Mass
-muscle atrophy develops secondary to altered protein metabolism

> Wound healing
-delayed wound healing occurs associated with suppressed inflammatory response

26
Q

Nursing Actions

A

> Administer medications that interfere with production/ secretion of cortisol
-decreases secretion of cortisol

> Head of the Bed Elevated 45 Degrees
-decreases work of breathing that may develop secondary to fluid retention

> Turn patient frequently and protect the skin from injury
-thinning of the skin along with increased friability of the skin accompanied by fluid retention increase the chances of skin injury caused by pressure or friction

27
Q

Teaching

A

> Overview of the Disease process
-important to detect early signs of both hypercortisolism and adrenal insufficiency

> Importance of taking prescribed medications
-medications that interfere with cortisol production are key to disease management

> Modify Salt in Diet as directed
-excessive salt intake may further exacerbate fluid retention

28
Q

Evaluating Care Outcomes

A
  • if etiology is a hypersecreting tumor of the pituitary gland or adrenal cortex, surgical intervention (transsphenoidal hypophysectomy, adrenalectomy, stereotactic radiosurgery) is indicated
  • be closely monitored postoperatively and may require lifelong corticosteroid replacement on the basis of the surgical outcome
  • stable vital signs and fluid volume status, serum electrolytes within normal limits, and intact skin are expected outcomes with treatment of hyperfunction of the adrenal cortex